Ontology highlight
ABSTRACT:
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Cell Culture, Fibroblast
DISEASE(S): Skin Cancer
SUBMITTER:
AUDEBERT Stephane
LAB HEAD: Deckert Marcel
PROVIDER: PXD026645 | Pride | 2021-11-12
REPOSITORIES: Pride
| Action | DRS | |||
|---|---|---|---|---|
| Garlau_Rep1.raw | Raw | |||
| Garlau_Rep1_180830201633.raw | Raw | |||
| Garlau_Rep1_180830225548.raw | Raw | |||
| Garlau_Rep2_180903003222.raw | Raw | |||
| Garlau_Rep2_180903031139.raw | Raw |
Items per page: 5 1 - 5 of 38 |

Berestjuk Ilona I Lecacheur Margaux M Carminati Alexandrine A Diazzi Serena S Rovera Christopher C Prod'homme Virginie V Ohanna Mickael M Popovic Ana A Mallavialle Aude A Larbret Frédéric F Pisano Sabrina S Audebert Stéphane S Passeron Thierry T Gaggioli Cédric C Girard Christophe A CA Deckert Marcel M Tartare-Deckert Sophie S
EMBO molecular medicine 20211227 2
Resistance to BRAF/MEK inhibitor therapy in BRAF<sup>V600</sup> -mutated advanced melanoma remains a major obstacle that limits patient benefit. Microenvironment components including the extracellular matrix (ECM) can support tumor cell adaptation and tolerance to targeted therapy; however, the underlying mechanisms remain poorly understood. Here, we investigated the process of matrix-mediated drug resistance (MMDR) in response to BRAF<sup>V600</sup> pathway inhibition in melanoma. We demonstrat ...[more]